Taken together, GATA4 and ETS1 overexpression mediated by MLL mutation enhanced the ability of drug-resistant to epirubicin which endowed mutated bladder tumor cells the advantage of survival and recurrence in the presence of chemotherapeutics. The gene discussed is KMT2A; the disease is urinary bladder neoplasm.